arrow
A

Amanika Kumar

Mayo Clinic
H指数:27
被引数:2,601

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer

静脉注射表达甲状腺钠碘 symporter(NIS)和人类干扰素β(hIFNβ)的vesicular stomatitis virus 在转移性或复发性子宫内膜癌中的I期临床试验

2026-11-050
PRE
Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

预测卵巢癌新辅助化疗后的残余病灶和手术范围:MSKCC模型是否适用于初始设置?

2026-08-010
PRE
Multi-center, international endometrial cancer consortium highlights

多中心、国际子宫内膜癌联盟重点内容

2025-05-010
PRE
Racial/ethnic, socioeconomic, and healthcare access disparities in achieving textbook oncologic outcome in advanced ovarian cancer

种族/族裔、社会经济地位和医疗保健可及性差异在实现晚期卵巢癌教科书式肿瘤学结局中的作用

2025-04-010
PRE
Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients
2020-10-1460
OAAI
The senescence-associated secretome as an indicator of age and medical risk
2020-06-18237
OA